Header cover image

Pakistani (KSE) Pharma Industry Analysis

UpdatedAug 20, 2026
DataAggregated Company Financials
Companies11
  • 7D-1.6%
  • 3M1.2%
  • 1Y-18.0%
  • YTD-15.5%

Over the last 7 days, the Pharma industry has dropped 1.6%, driven by declines in AGP and Abbott Laboratories (Pakistan) of 4.0% and 2.3%, respectively. Overall the industry is down 18% in 12 months. Earnings are forecast to grow by 11% annually.

Industry Valuation and Performance

Has the Pakistani Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 20 Aug 2026PK₨446.0bPK₨316.6bPK₨34.3b13.9x13x1.4x
Sat, 18 Jul 2026PK₨461.1bPK₨316.6bPK₨34.3b14.3x13.5x1.5x
Mon, 15 Jun 2026PK₨450.7bPK₨316.6bPK₨34.3b13.4x13.2x1.4x
Wed, 13 May 2026PK₨446.4bPK₨316.6bPK₨34.3b13.2x13x1.4x
Fri, 10 Apr 2026PK₨460.5bPK₨311.0bPK₨32.8b13.9x14.1x1.5x
Sun, 08 Mar 2026PK₨431.8bPK₨304.4bPK₨30.1b14x14.3x1.4x
Tue, 03 Feb 2026PK₨532.8bPK₨297.3bPK₨29.2b16.9x18.3x1.8x
Thu, 01 Jan 2026PK₨506.1bPK₨297.4bPK₨29.4b15.4x17.2x1.7x
Sat, 29 Nov 2025PK₨501.1bPK₨297.4bPK₨29.4b15.9x17.1x1.7x
Mon, 27 Oct 2025PK₨529.7bPK₨291.2bPK₨29.6b22.7x17.9x1.8x
Wed, 24 Sep 2025PK₨544.9bPK₨285.7bPK₨29.0b23.6x18.8x1.9x
Fri, 22 Aug 2025PK₨540.9bPK₨281.2bPK₨26.5b25.4x20.4x1.9x
Sun, 20 Jul 2025PK₨484.0bPK₨279.5bPK₨26.2b22.5x18.4x1.7x
Tue, 17 Jun 2025PK₨460.4bPK₨279.5bPK₨26.2b21.7x17.6x1.6x
Thu, 15 May 2025PK₨435.7bPK₨279.4bPK₨25.7b17.4x16.9x1.6x
Sat, 12 Apr 2025PK₨494.8bPK₨272.6bPK₨23.2b21.7x21.3x1.8x
Mon, 10 Mar 2025PK₨468.8bPK₨263.7bPK₨20.8b24.9x22.5x1.8x
Wed, 05 Feb 2025PK₨482.8bPK₨257.1bPK₨19.2b23.1x25.2x1.9x
Fri, 03 Jan 2025PK₨488.7bPK₨257.1bPK₨19.2b23.2x25.5x1.9x
Sun, 01 Dec 2024PK₨433.8bPK₨257.0bPK₨19.0b21.7x22.8x1.7x
Tue, 29 Oct 2024PK₨329.4bPK₨247.9bPK₨15.0b19.5x21.9x1.3x
Thu, 26 Sep 2024PK₨281.4bPK₨251.2bPK₨12.3b17.2x22.8x1.1x
Sat, 24 Aug 2024PK₨266.9bPK₨243.6bPK₨8.3b18.4x32.3x1.1x
Mon, 22 Jul 2024PK₨248.3bPK₨243.6bPK₨8.3b17x30x1x
Wed, 19 Jun 2024PK₨244.7bPK₨243.6bPK₨8.3b16.3x29.6x1x
Fri, 17 May 2024PK₨224.8bPK₨234.6bPK₨9.0b27.7x24.8x1x
Sun, 14 Apr 2024PK₨189.4bPK₨228.8bPK₨6.6b34.8x28.8x0.8x
Tue, 12 Mar 2024PK₨169.1bPK₨222.9bPK₨6.3b21.4x26.7x0.8x
Thu, 08 Feb 2024PK₨165.8bPK₨221.2bPK₨6.3b20.2x26.4x0.7x
Sat, 06 Jan 2024PK₨169.9bPK₨221.2bPK₨6.3b20.6x27x0.8x
Mon, 04 Dec 2023PK₨172.4bPK₨218.2bPK₨6.2b21.7x27.8x0.8x
Wed, 01 Nov 2023PK₨140.1bPK₨211.7bPK₨6.6b15.8x21.2x0.7x
Fri, 29 Sep 2023PK₨122.9bPK₨209.3bPK₨8.2b11.9x14.9x0.6x
Sun, 27 Aug 2023PK₨131.2bPK₨205.6bPK₨8.7b11.7x15x0.6x
Price to Earnings Ratio

15x


Total Market Cap: PK₨131.2bTotal Earnings: PK₨8.7bTotal Revenue: PK₨205.6bTotal Market Cap vs Earnings and Revenue0%0%0%
Pakistani Pharma Industry Price to Earnings3Y Average 20.8x202420252026
Current Industry PE
  • Investors are pessimistic on the Pakistani Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 13.0x which is lower than its 3-year average PE of 20.8x.
  • The industry is trading close to its 3-year average PS ratio of 1.3x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 58% per year over the last three years.
  • Revenues for these companies have grown 15% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Pakistani Healthcare industry?

PK Market-1.73%
Healthcare-1.83%
Pharma-1.55%
Pharma-1.55%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
HPL Hoechst PakistanPK₨4.15k4.1%
+PK₨1.6b
8.5%PE13.1x
BFBIO BF BiosciencesPK₨138.182.2%
+PK₨258.8m
-21.9%PE20.6x
CPHL Citi PharmaPK₨72.950.1%
+PK₨20.6m
-23.2%PE15.2x

Latest News